From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Open Letter to Paul Shackleton: Given the latest massive John Zorbas Alerion lie will you resign as MRS Nomad now?

By Tom Winnifrith | Monday 13 May 2019


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


China fraud specialist Paul Shackleton is trying to restore his soiled reputation and personal finances as head of the Nomad team at Arden. But this is proving hard given the activities of Arden client Management Resource Solutions (MRS). Over the weekend, thanks to Winnileaks, we exposed the biggest lie yet told by Management boss John Zorbas over the dodgy as hell related party nest of snakes £1.32 million acquisition of Alerion. In friendship, I have written to Mr Shackleton asking if Arden will quit as Nomad now and explaining exactly why they must. I have cc’d in AIM Regulation.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:24:09